StaffThe Daily Hit is a recap of the top financial news stories for Monday, December 2, 2024.
On the Site
Rescheduling hearing starts under cloud of allegations
The DEA is attempting to reschedule cannabis from a Schedule1 drug under the CSA to a Schedule 3 drug.
Read more here.
Simply Solventless gives glowing guidance for the fourth quarter
The company’s acquisitions have boosted its revenue.
Read more here.
As Cansortium’s revenue grows, it says it is fine with adult-use not passing in Florida
Cansortium said its growth strategy did not depend on the outcome of Amendment 3 passing in Florida.
Read more here.
Entourage Health revenues grow as it stays one step ahead of lenders
The company’s cash burn is slowing as it works with lenders on debt payments.
Read more here.
Michigan is building a cannabis testing lab — but needs a lame-duck vote to run it
Is the Michigan Cannabis Regulatory Agency’s long-awaited reference testing lab in trouble?
Read more here.
In Other News
Trump taps Florida sheriff Chad Chronister to lead DEA
President-elect Donald Trump has announced he will nominate Sheriff Chad Chronister to serve as the next administer of the U.S. Drug Enforcement Agency.
Read more here.
